If a patient with atrial fibrillation has a creatinine clearance of 40 mL/min, what would be the appropriate dose of apixaban?

In patients with atrial fibrillation, the dose of apixaban is adjusted based on renal function, specifically the creatinine clearance (CrCl). For a patient with a creatinine clearance of 40 mL/min, the recommended dose of apixaban is 5 mg twice daily.

In patients with CrCl between 15 to 50 mL/min, the standard dose is typically reduced from the 5 mg twice daily dosage to 2.5 mg twice daily. However, for those who have additional risk factors such as age greater than 80 years, body weight less than 60 kg, or the presence of concomitant medications that can increase apixaban levels, the 2.5 mg dosing may be necessary.

In this scenario, if the patient does not have any of those additional risk factors, 5 mg twice daily is appropriate. Thus, for a patient with a creatinine clearance of 40 mL/min, if they do not meet the criteria for further dose reduction, the recommended dose is indeed 5 mg twice daily. In contrast, the lower dosage of 2.5 mg twice daily would be required only if they met the specified risk criteria.

The other options do not align with